Related references
Note: Only part of the references are listed.Discovery and characterization of orally bioavailable 4-chloro-6-fluoroi-sophthalamides as covalent PPARG inverse-agonists
Douglas L. Orsi et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2023)
Structure and function of SARS-CoV and SARS-CoV-2 main proteases and their inhibition: A comprehensive review
Xin Li et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2023)
Arylalkynyl amide-type peroxisome proliferator-activated receptor γ (PPARγ)-selective antagonists covalently bind to the PPARγ ligand binding domain with a unique binding mode
Mami Yoshizawa et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2022)
Prostaglandin A2 Interacts with Nurr1 and Ameliorates Behavioral Deficits in Parkinson's Disease Fly Model
Sreekanth Rajan et al.
NEUROMOLECULAR MEDICINE (2022)
Reactive chemistry for covalent probe and therapeutic development
R. Justin Grams et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2022)
Discovery and Structure-Based Design of Potent Covalent PPARγ Inverse-Agonists BAY-4931 and BAY-0069
Douglas L. Orsi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2022)
Covalent Warheads Targeting Cysteine Residue: The Promising Approach in Drug Development
Fangjiao Huang et al.
MOLECULES (2022)
Medicinal Chemistry and Chemical Biology of Nurr1 Modulators: An Emerging Strategy in Neurodegeneration
Sabine Willems et al.
JOURNAL OF MEDICINAL CHEMISTRY (2022)
Advances in covalent drug discovery
Lydia Boike et al.
NATURE REVIEWS DRUG DISCOVERY (2022)
Discovery and Structure-Based Design of Potent Covalent PPAR gamma Inverse-Agonists BAY-4931 and BAY-0069
Douglas L. Orsi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2022)
Potent synthetic and endogenous ligands for the adopted orphan nuclear receptor Nurr1
Yongwoo Jang et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2021)
10 years into the resurgence of covalent drugs
Elena De Vita
FUTURE MEDICINAL CHEMISTRY (2021)
UniProt: the universal protein knowledgebase in 2021
Alex Bateman et al.
NUCLEIC ACIDS RESEARCH (2021)
Orally effective FDA-approved protein kinase targeted covalent inhibitors (TCIs)
Robert Roskoski
PHARMACOLOGICAL RESEARCH (2021)
Mechanistic insights into the synergistic activation of the RXR-PXR heterodimer by endocrine disruptor mixtures
Vanessa Delfosse et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
Covalent Occlusion of the RORγt Ligand Binding Pocket Allows Unambiguous Targeting of an Allosteric Site
Femke A. Meijer et al.
ACS MEDICINAL CHEMISTRY LETTERS (2021)
HNF4α Is a Covalent Bond Forming Receptor
Satoshi Kanamori et al.
JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY (2021)
Electrophilic Natural Products as Drug Discovery Tools
Paul Gehrtz et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2021)
Fragment-based covalent ligand discovery
Wenchao Lu et al.
RSC CHEMICAL BIOLOGY (2021)
DrugCentral 2021 supports drug discovery and repositioning
Sorin Avram et al.
NUCLEIC ACIDS RESEARCH (2021)
Nuclear receptors are the major targets of endocrine disrupting chemicals
Lucia Toporova et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2020)
A novel series of cysteine-dependent, allosteric inverse agonists of the nuclear receptor RORγt
Xin Jiang et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2020)
PGE1 and PGA1 bind to Nurr1 and activate its transcriptional function
Sreekanth Rajan et al.
NATURE CHEMICAL BIOLOGY (2020)
Nuclear Receptor Chemical Reporter Enables Domain-Specific Analysis of Ligands in Mammalian Cells
Taku Tsukidate et al.
ACS CHEMICAL BIOLOGY (2020)
Nuclear Hormone Receptors and Their Ligands: Metabolites in Control of Transcription
Lian Jing Tao et al.
CELLS (2020)
Covalent inhibitors: a rational approach to drug discovery
Fandi Sutanto et al.
RSC MEDICINAL CHEMISTRY (2020)
Estrogen Receptor Covalent Antagonists: The Best Is Yet to Come
Craig Furman et al.
CANCER RESEARCH (2019)
Identification of New Small Molecule Inducers of Estrogen-related Receptor α (ERRα) Degradation
Lijie Peng et al.
ACS MEDICINAL CHEMISTRY LETTERS (2019)
Molecular, chemical, and structural characterization of prostaglandin A2 as a novel agonist for Nur77
Sowmya P. Lakshmi et al.
BIOCHEMICAL JOURNAL (2019)
Emerging and Re-Emerging Warheads for Targeted Covalent Inhibitors: Applications in Medicinal Chemistry and Chemical Biology
Matthias Gehringer et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Covalent Modification and Regulation of the Nuclear Receptor Nurr1 by a Dopamine Metabolite
John M. Bruning et al.
CELL CHEMICAL BIOLOGY (2019)
The Cysteinome of Protein Kinases as a Target in Drug Development
Apirat Chaikuad et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2018)
The Taxonomy of Covalent Inhibitors
Alfred Tuley et al.
BIOCHEMISTRY (2018)
Progress with covalent small-molecule kinase inhibitors
Zheng Zhao et al.
DRUG DISCOVERY TODAY (2018)
Identification of the Histidine Residue in Vitamin D Receptor That Covalently Binds to Electrophilic Ligands
Mami Yoshizawa et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Cysteine Metabolism in Neuronal Redox Homeostasis
Bindu D. Paul et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2018)
Proteome-wide analysis of cysteine oxidation reveals metabolic sensitivity to redox stress
Jiska van der Reest et al.
NATURE COMMUNICATIONS (2018)
Discovery of Selective Estrogen Receptor Covalent Antagonists for the Treatment of ERαWT and ERαMUT Breast Cancer
Xiaoling Puyang et al.
CANCER DISCOVERY (2018)
The nuclear receptor superfamily: A structural perspective
Emily R. Weikum et al.
PROTEIN SCIENCE (2018)
Identification and Molecular Characterization of Peroxisome Proliferator-Activated Receptor δ as a Novel Target for Covalent Modification by 15-Deoxy-Δ12,14-prostaglandin J2
Aravind T. Reddy et al.
ACS CHEMICAL BIOLOGY (2018)
PPAR gamma-K107 SUMOylation regulates insulin sensitivity but not adiposity in mice
Takeshi Katafuchi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
A structural mechanism for directing corepressorselective inverse agonism of PPARγ
Richard Brust et al.
NATURE COMMUNICATIONS (2018)
Cooperative cobinding of synthetic and natural ligands to the nuclear receptor PPARγ
Jinsai Shang et al.
ELIFE (2018)
A comprehensive map of molecular drug targets
Rita Santos et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
Cysteine Modifications in the Pathogenesis of ALS
Cristiana Valle et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2017)
Cysteines as Redox Molecular Switches and Targets of Disease
Annamaria Fra et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2017)
Selective Glucocorticoid Receptor Properties of GSK866 Analogs with Cysteine Reactive Warheads
Chandra S. Chirumamilla et al.
FRONTIERS IN IMMUNOLOGY (2017)
Features of reactive cysteines discovered through computation: from kinase inhibition to enrichment around protein degrons
Nicholas J. Fowler et al.
SCIENTIFIC REPORTS (2017)
On-site reaction for PPARγ modification using a specific bifunctional ligand
Hiroyuki Kojima et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2017)
Structural and functional evidences for the interactions between nuclear hormone receptors and endocrine disruptors at low doses
Patrick Balaguer et al.
COMPTES RENDUS BIOLOGIES (2017)
17-OxoDHA Is a PPARα/γ Dual Covalent Modifier and Agonist
Daichi Egawa et al.
ACS CHEMICAL BIOLOGY (2016)
Chemical Protein Modification through Cysteine
Smita B. Gunnoo et al.
CHEMBIOCHEM (2016)
Covalent targeting of acquired cysteines in cancer
Marieke Visscher et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2016)
Disulfide-Trapping Identifies a New, Effective Chemical Probe for Activating the Nuclear Receptor Human LRH-1 (NR5A2)
Felipe de Jesus Cortez et al.
PLOS ONE (2016)
Characterization of Covalent Bond Formation between PPARγ and Oxo-Fatty Acids
Daichi Egawa et al.
BIOCONJUGATE CHEMISTRY (2015)
The cysteine proteome
Young-Mi Go et al.
FREE RADICAL BIOLOGY AND MEDICINE (2015)
Botanical compounds and their regulation of nuclear receptor action: The case of traditional Chinese medicine
Ling Li et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2015)
Nuclear receptor Nurr1 agonists enhance its dual functions and improve behavioral deficits in an animal model of Parkinson's disease
Chun-Hyung Kim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Structural basis for PPARγ transactivation by endocrine-disrupting organotin compounds
Shusaku Harada et al.
SCIENTIFIC REPORTS (2015)
A structural perspective on nuclear receptors as targets of environmental compounds
Vanessa Delfosse et al.
ACTA PHARMACOLOGICA SINICA (2015)
Targeting Nuclear Receptors with Marine Natural Products
Chunyan Yang et al.
MARINE DRUGS (2014)
Developing Irreversible Inhibitors of the Protein Kinase Cysteinome
Qingsong Liu et al.
CHEMISTRY & BIOLOGY (2013)
Understanding nuclear receptor form and function using structural biology
Fraydoon Rastinejad et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2013)
PPARγ signaling and metabolism: the good, the bad and the future
Maryam Ahmadian et al.
NATURE MEDICINE (2013)
NURR1 in Parkinson disease-from pathogenesis to therapeutic potential
Mickael Decressac et al.
NATURE REVIEWS NEUROLOGY (2013)
Revealing a natural marine product as a novel agonist for retinoic acid receptors with a unique binding mode and inhibitory effects on cancer cells
Shanshan Wang et al.
BIOCHEMICAL JOURNAL (2012)
Brown Remodeling of White Adipose Tissue by SirT1-Dependent Deacetylation of Pparγ
Li Qiang et al.
CELL (2012)
General Molecular Biology and Architecture of Nuclear Receptors
Michal Pawlak et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2012)
Natural Ligands for Nuclear Receptors: Biology and Potential Therapeutic Applications
Maria Valeria D'Auria et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2012)
Development of FXR, PXR and CAR Agonists and Antagonists for Treatment of Liver Disorders
Stefano Fiorucci et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2012)
Plakilactones from the Marine Sponge Plakinastrella mamillaris. Discovery of a New Class of Marine Ligands of Peroxisome Proliferator-Activated Receptor γ
Carmen Festa et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Discovery That Theonellasterol a Marine Sponge Sterol Is a Highly Selective FXR Antagonist That Protects against Liver Injury in Cholestasis
Barbara Renga et al.
PLOS ONE (2012)
Marine sponge steroids as nuclear receptor ligands
Stefano Fiorucci et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2012)
Formation and Signaling Actions of Electrophilic Lipids
Francisco J. Schopfer et al.
CHEMICAL REVIEWS (2011)
LigPlot+: Multiple Ligand-Protein Interaction Diagrams for Drug Discovery
Roman A. Laskowski et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2011)
What are nuclear receptor ligands?
Frances M. Sladek
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2011)
The resurgence of covalent drugs
Juswinder Singh et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
Structural basis of the histidine-mediated vitamin D receptor agonistic and antagonistic mechanisms of (23S)-25-dehydro-1α-hydroxyvitamin D3-26,23-lactone
Shinji Kakuda et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2010)
A structural view of nuclear hormone receptor: endocrine disruptor interactions
Albane le Maire et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2010)
The nuclear receptor PPARγ individually responds to serotonin- and fatty acid-metabolites
Tsuyoshi Waku et al.
EMBO JOURNAL (2010)
Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARγ by Cdk5
Jang Hyun Choi et al.
NATURE (2010)
Bioorthogonal Chemistry: Fishing for Selectivity in a Sea of Functionality
Ellen M. Sletten et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2009)
Chemical Modification of Proteins at Cysteine: Opportunities in Chemistry and Biology
Justin M. Chalker et al.
CHEMISTRY-AN ASIAN JOURNAL (2009)
Activation of RXR-PPAR heterodimers by organotin environmental endocrine disruptors
Albane le Maire et al.
EMBO REPORTS (2009)
Structural Insight into PPARγ Activation Through Covalent Modification with Endogenous Fatty Acids
Tsuyoshi Waku et al.
JOURNAL OF MOLECULAR BIOLOGY (2009)
Endocrine disruption induced by organotin compounds; organotins function as a powerful agonist for nuclear receptors rather than an aromatase inhibitor
Tsuyoshi Nakanishi
JOURNAL OF TOXICOLOGICAL SCIENCES (2008)
Structure of the intact PPAR-γ-RXR-α nuclear receptor complex on DNA
Vikas Chandra et al.
NATURE (2008)
Structural basis for the activation of PPARγ by oxidized fatty acids
Toshimasa Itoh et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2008)
Endocrine-disrupting organotin compounds are potent inducers of adipogenesis in vertebrates
Felix Grun et al.
MOLECULAR ENDOCRINOLOGY (2006)
Bioassay for the identification of natural product-based activators of peroxisome proliferator-activated receptor-γ (PPAR-γ):: The marine sponge metabolite psammaplin A activates PPARγ and induces apoptosis in human breast tumor cells
FD Mora et al.
JOURNAL OF NATURAL PRODUCTS (2006)
Identification of covalent attachment site of antiestrogenic estradiol 11β-derivatives on human estrogen receptor α ligand-binding domain
S Aliau et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2006)
Discovery of small molecule inhibitors of the interaction of the thyroid hormone receptor with transcriptional coregulators
LA Arnold et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
ProRule: a new database containing functional and structural information on PROSITE profiles
CJA Sigrist et al.
BIOINFORMATICS (2005)
Nuclear receptors -: A perspective from Drosophila
K King-Jones et al.
NATURE REVIEWS GENETICS (2005)
Thyroxine-thyroid hormone receptor interactions
B Sandler et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Identification of a selective inverse agonist for the orphan nuclear receptor estrogen-related receptor α
BB Busch et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Crystal structure of the glucocorticoid receptor ligand binding domain reveals a novel mode of receptor dimerization and coactivator recognition
RK Bledsoe et al.
CELL (2002)
Functional consequences of cysteine modification in the ligand binding sites of peroxisome proliferator activated receptors by GW9662
LM Leesnitzer et al.
BIOCHEMISTRY (2002)
Molecular modeling, affinity labeling, and site-directed mutagenesis define the key points of interaction between the ligand-binding domain of the vitamin D nuclear receptor and 1α,25-dihydroxyvitamin D3
N Swamy et al.
BIOCHEMISTRY (2000)
Relationship between the occurrence of cysteine in proteins and the complexity of organisms
A Miseta et al.
MOLECULAR BIOLOGY AND EVOLUTION (2000)
Share Paper
